How to measure the treatment response in progressive multiple sclerosis: Current perspectives and limitations in clinical settings’
Authors:
- 10 June 2023
- journal article
- review article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 76, 104826
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Meningeal and cortical grey matter pathology in multiple sclerosisBMC Neurology, 2012
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology, 2010
- Validation of the Multiple Sclerosis International Quality of Life questionnaireMultiple Sclerosis Journal, 2007
- Natural history of multiple sclerosis: a unifying conceptBrain, 2006
- Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosisJournal of the Neurological Sciences, 2004
- Brain atrophy in clinically early relapsing–remitting multiple sclerosisBrain, 2002
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact ScaleClinical Infectious Diseases, 1994
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983